下载
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Overview
Catalog No. HV974406
Brand abinScience
Host species Human
Tested applications WB
Species reactivity Human
Form Liquid
Storage buffer 0.01M PBS pH 7.4
Purity >95% purity as determined by SDS-PAGE.
Clonality Monoclonal
Isotype IgG4-kappa
Applications ELISA, Bioactivity: FACS, Functional assay, Research in vivo, WB
Target B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, TGFR-2, TbetaR-II, TGF-beta type II receptor, TGFBR2, TGF-beta receptor type-2, TGF-beta receptor type II, Transforming growth factor-beta receptor type II
References 1. Bo Cheng, et al. Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer. Cancer Commun (Lond). 2022 Jan;42(1):17-36. [HV974406]
Purification Protein A/G purified from cell culture supernatant.
Biological activity SHR-1701 (10 ug/mL) can inhibit TGF-β signaling pathway, activate PI3K/Akt/Erk signaling pathway, rescue lymphocytes and restore the anti-tumor function of peripheral blood CD8 + T cells in patients with lung cancer [1].
Endotoxin level < 10 EU/mg
Expression system Mammalian cells
Accession Q9NZQ7 & P37173
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative nameSHR-1701
Product Usage Information
ApplicationDilution
WB 1:500-1:2000
Note For research use only. Not suitable for clinical or therapeutic use.
Images


SDS-PAGE
SDS-PAGE for Research Grade Retlirafusp Alfa.

Bioactivity
Detects recombinant PDL1 (Catalog No: HV974011) in indirect ELISA.

Western blot
Western blot analysis was performed using anti-PDL1 monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human PDL1 (Catalog No: HV974011)
Lane 2: Negative control